Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
Katsutoshi Sato(Icahn School of Medicine at Mount Sinai), E. Premkumar Reddy(Icahn School of Medicine at Mount Sinai)
Cited by 63